Abstract
Proteomics, the detailed understanding of the role that proteins play in health and disease, is a necessary complement to genetic analysis. Rapid progress within the proteomics field has opened up possibilities for direct intervention in the medical and clinical area where diseases, disease progression and cause of disease can be investigated at a molecular level. This review introduces the proteomics field, illustrating the link to disease and organ dysfunctions, and the problem-solving progress currently ongoing in other research areas. The proteomics research field is progressing through developments in novel technology that have recently driven the biological interpretation of proteomics studies forward. A personal overview is presented with examples from the areas of clinical proteomics, tissue imaging and profiling, as well as examples of targeted proteomics studies.
| Abbreviations | ||
| EGF | = | epidermal growth factor |
| EGF-R | = | epidermal growth factor receptor |
| HRCT | = | high-resolution computed tomography |
| HUPO | = | Human Proteome Organization |
| ICAT | = | isotope-coded affinity tagging |
| IL-10 | = | interleukin-10 |
| LTB4 | = | leukotriene B4 |
| LTC4 | = | leukotriene C4 |
| LUMIER | = | luminescence-based mammalian interaction mapping |
| MALDI | = | matrix-assisted laser desorption ionization |
| MS | = | mass spectrometry |
| PGB2 | = | prostaglandin B2 |
| TGF-β | = | transforming growth factor-β |
| Abbreviations | ||
| EGF | = | epidermal growth factor |
| EGF-R | = | epidermal growth factor receptor |
| HRCT | = | high-resolution computed tomography |
| HUPO | = | Human Proteome Organization |
| ICAT | = | isotope-coded affinity tagging |
| IL-10 | = | interleukin-10 |
| LTB4 | = | leukotriene B4 |
| LTC4 | = | leukotriene C4 |
| LUMIER | = | luminescence-based mammalian interaction mapping |
| MALDI | = | matrix-assisted laser desorption ionization |
| MS | = | mass spectrometry |
| PGB2 | = | prostaglandin B2 |
| TGF-β | = | transforming growth factor-β |